Up to 50 cats are expected to participate in the trial, with their weight and health metrics monitored at three and six ...
Congress has the power to make obesity treatment and weight management accessible to the communities that need it.
A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...
The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...
Neuroplasticity research shows that maternal brains are rewired for immense creativity and problem solving. How could GLP-1s ...
We knew that GLP-1 drugs like Ozempic and Wegovy did more than just help control type 2 diabetes and aid weight loss, but the ...
The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...
Usage of GLP-1 medications has increased over the past 18 months, with highest adoption among women and adults aged 50-64, ...
Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...
CKM syndrome, which links heart disease, kidney disease, diabetes, and obesity, is a fairly new concept. As a result, ...
The name "Ozempic 2.0" has been floating around on various outlets and on social media, as a trending nickname for the next generation of weight loss drugs that are in the works for 2026. Both Eli ...
From surgery to supplements, GLP-1 medications are radically evolving the beauty space. We unpack the latest innovations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results